Combining UBR5 and CD163+ tumor-associated macrophages better predicts prognosis of clear cell renal cell carcinoma patients

Author:

Wang Chao,Hong TianYu,Wang Yuning,Peng Guang,Yu Yongwei,Zhang Jing,Zhuo Dong,Zheng Jingcun,Ma Xiaojing,Cui XingangORCID

Funder

The Top-level Clinical Discipline Project of Shanghai Pudong

National Natural Science Foundation of China

Pudong New Area Science and technology development fund special fund for people's livelihood Research

the Program of Shanghai Academic/Technology Research Leader

Meng Chao Talent Training Program-Cultivation of Leading Talents Reserve

the Shanghai Medical Guidance (Chinese and Western Medicine) Science and Technology Support Project

Natural Science Foundation of Shanghai

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3